These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 18387221)

  • 21. Current and emerging therapies to prevent hereditary angioedema attacks.
    Lumry WR
    Am J Manag Care; 2018 Aug; 24(14 Suppl):S299-S307. PubMed ID: 30132644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of episodes of hereditary angioedema with C1 inhibitor: serial assessment of observed abnormalities of the plasma bradykinin-forming pathway and fibrinolysis.
    Joseph K; Tholanikunnel TE; Kaplan AP
    Ann Allergy Asthma Immunol; 2010 Jan; 104(1):50-4. PubMed ID: 20143645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flow-mediated vasodilation assay indicates no endothelial dysfunction in hereditary angioedema patients with C1-inhibitor deficiency.
    Nebenführer Z; Szabó E; Kajdácsi E; Kőhalmi KV; Karádi I; Zsáry A; Farkas H; Cervenak L
    Ann Allergy Asthma Immunol; 2019 Jan; 122(1):86-92. PubMed ID: 30312677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An evidence based therapeutic approach to hereditary and acquired angioedema.
    Bork K
    Curr Opin Allergy Clin Immunol; 2014 Aug; 14(4):354-62. PubMed ID: 24983294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis and management of hereditary angioedema.
    Johnston DT
    J Am Osteopath Assoc; 2011 Jan; 111(1):28-36. PubMed ID: 21258014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical review of hereditary angioedema: diagnosis and management.
    Weis M
    Postgrad Med; 2009 Nov; 121(6):113-20. PubMed ID: 19940422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. When is prophylaxis for hereditary angioedema necessary?
    Craig T; Riedl M; Dykewicz MS; Gower RG; Baker J; Edelman FJ; Hurewitz D; Jacobs J; Kalfus I
    Ann Allergy Asthma Immunol; 2009 May; 102(5):366-72. PubMed ID: 19492656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term prophylaxis of hereditary angioedema with a pasteurized C1 inhibitor concentrate.
    Tallroth GA
    Int Arch Allergy Immunol; 2011; 154(4):356-9. PubMed ID: 20975289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing hereditary angioedema management through tailored treatment approaches.
    Nasr IH; Manson AL; Al Wahshi HA; Longhurst HJ
    Expert Rev Clin Immunol; 2016; 12(1):19-31. PubMed ID: 26496459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progress in the emergency management of hereditary angioedema: focus on new treatment options in the United States.
    Bernstein JA; Moellman JJ
    Postgrad Med; 2012 May; 124(3):91-100. PubMed ID: 22691903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term prophylaxis of hereditary angioedema with androgen derivates: a critical appraisal and potential alternatives.
    Maurer M; Magerl M
    J Dtsch Dermatol Ges; 2011 Feb; 9(2):99-107. PubMed ID: 20946572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [National prevalence survey of hereditary angioedema in Japan].
    Iwamoto K; Mihara S; Ikezawa Z; Hide M
    Arerugi; 2011 Jan; 60(1):26-32. PubMed ID: 21346404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of long-term danazol treatment on haematological parameters in hereditary angioedema.
    Kőhalmi KV; Veszeli N; Zotter Z; Csuka D; Benedek S; Imreh É; Varga L; Farkas H
    Orphanet J Rare Dis; 2016 Feb; 11():18. PubMed ID: 26911866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral plasma kallikrein inhibitor BCX7353 for treatment of hereditary angioedema.
    Hwang JR; Hwang G; Johri A; Craig T
    Immunotherapy; 2019 Dec; 11(17):1439-1444. PubMed ID: 31635497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Berotralstat (BCX7353) is a novel oral prophylactic treatment for hereditary angioedema: Review of phase II and III studies.
    Manning ME; Kashkin JM
    Allergy Asthma Proc; 2021 Jul; 42(4):274-282. PubMed ID: 34127176
    [No Abstract]   [Full Text] [Related]  

  • 36. Short-term prophylaxis in hereditary angioedema due to deficiency of the C1-inhibitor--a long-term survey.
    Farkas H; Zotter Z; Csuka D; Szabó E; Nébenfűhrer Z; Temesszentandrási G; Jakab L; Varga L; Harmat G; Karádi I
    Allergy; 2012 Dec; 67(12):1586-93. PubMed ID: 23025435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update on therapeutic developments for hereditary angioedema.
    Christiansen SC; Zuraw BL
    Allergy Asthma Proc; 2009; 30(5):500-5. PubMed ID: 19843404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variability of prodromal signs and symptoms associated with hereditary angioedema attacks: a literature review.
    Kemp JG; Craig TJ
    Allergy Asthma Proc; 2009; 30(5):493-9. PubMed ID: 19843403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current treatment of hereditary angioedema: An update on clinical studies.
    Banerji A
    Allergy Asthma Proc; 2010; 31(5):398-406. PubMed ID: 20929607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hereditary angioedema: management of laryngeal attacks.
    Christiansen SC; Zuraw BL
    Am J Rhinol Allergy; 2011; 25(6):379-82. PubMed ID: 22185739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.